0

Close
 
Upcoming Allied Market Research
2023
Hypothermia Management Market

Hypothermia Management Market

by Product (Warming Systems, Patient Cooling Systems), by Application (Preoperative Care, Acute Care, New-born Care, Others) and by Medical Specialty (Cardiology, Neurology, Pediatrics, Orthopedic, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A13352
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Hypothermia Management Market

Request Now !

Hypothermia is a medical condition, which leads to abnormal loss of body heat. This results in low body temperature, which can further exacerbate fatality. The condition occurs due to prolonged exposures to cold temperatures. Age and exhaustion are risk factors associated with hypothermia.

Hypothermia management involves warming systems, which include external rewarming and internal rewarming. These entail applying warming devices such as heating blanket. Furthermore, active rewarming involves use of irrigation of body activities with warm fluids and use of extracorporeal such as heart lung machine. Different forms of hypothermia is at times used as a potent alternative against treatment of brain injury. An example of this is deep hypothermic circulatory arrest, which involves cooling of brain to bring it to subzero temperatures for treatment of aneurysms.

COVID-19 Impact Analysis

Increase has been witnessed in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. The need for medical supplies has increased significantly among both from healthcare professionals and civil population for precautionary measures, owing to rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the global hypothermia management market.

Top Impacting Factors

  • Increase in the incidents of chronic diseases occurring across the globe coupled with rising awareness of hypothermia plus growing underlying demand for advanced therapeutics is anticipated to drive market growth for hypothermia management market.
  • Growing number of organic collaborations happening between various market players especially in developed regions is additionally anticipated to drive market growth of hypothermia management mechanisms. This further includes different mergers and acquisitions currently at fulcrum with respect to pharmaceutical and healthcare industry.
  • Increasing prevalence of low cost treatment options available pertaining to hypothermia is anticipated to further market penetration in emerging economies with high population base such as India and China.
  • Additionally, favorable reimbursement scenarios coupled with robust government support through influx of huge sums of investments in pharmaceuticals industry may further drive the market.
  • However, high costs associated with design, development, and positioning of hypothermia treatment mechanisms may hamper market growth especially in regions, which lack economic power and very low purchasing power parity.

Key Market Trends

  • North America is anticipated to witness huge gains with respect to hypothermia management market owing to rising prevalence of cardiovascular incidents in the region coupled with growing shift towards a quick, efficient, and accurate therapeutic mechanisms and rising disposable incomes to spend on healthcare.
  • 3M has recently developed its Bair Hugger product portfolio which primarily deals with underbody and full body blankets as a restraint strategy against extreme cold temperatures.
  • In January 2018, AltrixTM launched by Stryker Corporation to be used in all clinical settings for precision temperature management.
  • In June 2018, MTRE Advanced Technologies Ltd. acquired by Belmont Instrument LLC. as part of inclusion of non-invasive body temperature management solutions in the company portfolio.
  • In 2019, Advanced Cooling Therapy (ACT) received approval for their new device launch Esophageal Cooling Device (ECD). The deal was made as a bigger collaboration with Stryker’s Altrix Precision Temperature Management System (PTMS).

Key Benefits of the Report

  • This study presents the analytical depiction of the hypothermia management industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the hypothermia management market share.
  • The current market is quantitatively analyzed to highlight the hypothermia management growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Hypothermia Management Report

  • Which are the leading players active in the hypothermia management market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the hypothermia management market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is hypothermia management?
  • What is the hypothermia management market prediction in the future?
  • What are the current trends and predicted trends?

 Hypothermia Management Market Report Highlights

Aspects Details
By Product
  • Warming Systems
  • Patient Cooling Systems
By Application
  • Preoperative Care
  • Acute Care
  • New-born Care
  • Others
By Medical Specialty
  • Cardiology
  • Neurology
  • Pediatrics
  • Orthopedic
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Smiths Medical, Inc., 3M Company, Inditherm Plc, The 37Company, Medtronic, Atom Medical Corporation, Cincinnati Sub-Zero Products, LLC., Stryker Corporation, Geratherm Medical AG, ZOLL Medical Corporation, Bard Medical, Inc.
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: HYPOTHERMIA MANAGEMENT MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Warming Systems

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Patient Cooling Systems

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: HYPOTHERMIA MANAGEMENT MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Preoperative Care

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Acute Care

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. New-born Care

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: HYPOTHERMIA MANAGEMENT MARKET, BY MEDICAL SPECIALTY

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Medical Specialty

    • 6.2. Cardiology

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Neurology

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Pediatrics

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Orthopedic

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Others

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: HYPOTHERMIA MANAGEMENT MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By Medical Specialty

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Hypothermia Management Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By Medical Specialty

      • 7.2.7. Canada Hypothermia Management Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By Medical Specialty

      • 7.2.8. Mexico Hypothermia Management Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By Medical Specialty

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By Medical Specialty

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Hypothermia Management Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By Medical Specialty

      • 7.3.7. Germany Hypothermia Management Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By Medical Specialty

      • 7.3.8. Italy Hypothermia Management Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By Medical Specialty

      • 7.3.9. Spain Hypothermia Management Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By Medical Specialty

      • 7.3.10. UK Hypothermia Management Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By Medical Specialty

      • 7.3.11. Russia Hypothermia Management Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By Medical Specialty

      • 7.3.12. Rest Of Europe Hypothermia Management Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By Medical Specialty

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By Medical Specialty

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Hypothermia Management Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By Medical Specialty

      • 7.4.7. Japan Hypothermia Management Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By Medical Specialty

      • 7.4.8. India Hypothermia Management Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By Medical Specialty

      • 7.4.9. South Korea Hypothermia Management Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By Medical Specialty

      • 7.4.10. Australia Hypothermia Management Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By Medical Specialty

      • 7.4.11. Thailand Hypothermia Management Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By Medical Specialty

      • 7.4.12. Malaysia Hypothermia Management Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By Medical Specialty

      • 7.4.13. Indonesia Hypothermia Management Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By Medical Specialty

      • 7.4.14. Rest of Asia Pacific Hypothermia Management Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By Medical Specialty

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By Medical Specialty

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Hypothermia Management Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By Medical Specialty

      • 7.5.7. South Africa Hypothermia Management Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By Medical Specialty

      • 7.5.8. Saudi Arabia Hypothermia Management Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By Medical Specialty

      • 7.5.9. UAE Hypothermia Management Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By Medical Specialty

      • 7.5.10. Argentina Hypothermia Management Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By Medical Specialty

      • 7.5.11. Rest of LAMEA Hypothermia Management Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By Medical Specialty

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Stryker Corporation

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Medtronic

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. ZOLL Medical Corporation

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Bard Medical, Inc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Cincinnati Sub-Zero Products, LLC.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. 3M Company

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Smiths Medical, Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Geratherm Medical AG

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. The 37Company

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Inditherm Plc

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Atom Medical Corporation

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL HYPOTHERMIA MANAGEMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR WARMING SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR PATIENT COOLING SYSTEMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL HYPOTHERMIA MANAGEMENT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR PREOPERATIVE CARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR ACUTE CARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR NEW-BORN CARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL HYPOTHERMIA MANAGEMENT MARKET, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR CARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR NEUROLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR PEDIATRICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR ORTHOPEDIC, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL HYPOTHERMIA MANAGEMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL HYPOTHERMIA MANAGEMENT MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA HYPOTHERMIA MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 20. U.S. HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. U.S. HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. U.S. HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 23. CANADA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. CANADA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. CANADA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE HYPOTHERMIA MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 33. FRANCE HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. GERMANY HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 39. ITALY HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. ITALY HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. ITALY HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 45. UK HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. UK HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. UK HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 48. RUSSIA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. RUSSIA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. REST OF EUROPE HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC HYPOTHERMIA MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 58. CHINA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. CHINA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. CHINA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 61. JAPAN HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. JAPAN HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 64. INDIA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. INDIA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. INDIA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 70. AUSTRALIA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. AUSTRALIA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 73. THAILAND HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 74. THAILAND HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 76. MALAYSIA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. MALAYSIA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 79. INDONESIA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 80. INDONESIA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 85. LAMEA HYPOTHERMIA MANAGEMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 86. LAMEA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 89. BRAZIL HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 90. BRAZIL HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH AFRICA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 93. SOUTH AFRICA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 95. SAUDI ARABIA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 96. SAUDI ARABIA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 98. UAE HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 99. UAE HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 100. UAE HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 101. ARGENTINA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 102. ARGENTINA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 104. REST OF LAMEA HYPOTHERMIA MANAGEMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. REST OF LAMEA HYPOTHERMIA MANAGEMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA HYPOTHERMIA MANAGEMENT, BY MEDICAL SPECIALTY, 2022-2032 ($MILLION)
  • TABLE 107. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 108. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 109. STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 110. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 111. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. MEDTRONIC: KEY EXECUTIVES
  • TABLE 113. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 114. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 115. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 116. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. ZOLL MEDICAL CORPORATION: KEY EXECUTIVES
  • TABLE 118. ZOLL MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 119. ZOLL MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 120. ZOLL MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 121. ZOLL MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. BARD MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 123. BARD MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 124. BARD MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 125. BARD MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 126. BARD MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. CINCINNATI SUB-ZERO PRODUCTS, LLC.: KEY EXECUTIVES
  • TABLE 128. CINCINNATI SUB-ZERO PRODUCTS, LLC.: COMPANY SNAPSHOT
  • TABLE 129. CINCINNATI SUB-ZERO PRODUCTS, LLC.: OPERATING SEGMENTS
  • TABLE 130. CINCINNATI SUB-ZERO PRODUCTS, LLC.: PRODUCT PORTFOLIO
  • TABLE 131. CINCINNATI SUB-ZERO PRODUCTS, LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. 3M COMPANY: KEY EXECUTIVES
  • TABLE 133. 3M COMPANY: COMPANY SNAPSHOT
  • TABLE 134. 3M COMPANY: OPERATING SEGMENTS
  • TABLE 135. 3M COMPANY: PRODUCT PORTFOLIO
  • TABLE 136. 3M COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. SMITHS MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 138. SMITHS MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 139. SMITHS MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 140. SMITHS MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 141. SMITHS MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. GERATHERM MEDICAL AG: KEY EXECUTIVES
  • TABLE 143. GERATHERM MEDICAL AG: COMPANY SNAPSHOT
  • TABLE 144. GERATHERM MEDICAL AG: OPERATING SEGMENTS
  • TABLE 145. GERATHERM MEDICAL AG: PRODUCT PORTFOLIO
  • TABLE 146. GERATHERM MEDICAL AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. THE 37COMPANY: KEY EXECUTIVES
  • TABLE 148. THE 37COMPANY: COMPANY SNAPSHOT
  • TABLE 149. THE 37COMPANY: OPERATING SEGMENTS
  • TABLE 150. THE 37COMPANY: PRODUCT PORTFOLIO
  • TABLE 151. THE 37COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. INDITHERM PLC: KEY EXECUTIVES
  • TABLE 153. INDITHERM PLC: COMPANY SNAPSHOT
  • TABLE 154. INDITHERM PLC: OPERATING SEGMENTS
  • TABLE 155. INDITHERM PLC: PRODUCT PORTFOLIO
  • TABLE 156. INDITHERM PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 157. ATOM MEDICAL CORPORATION: KEY EXECUTIVES
  • TABLE 158. ATOM MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 159. ATOM MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 160. ATOM MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 161. ATOM MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL HYPOTHERMIA MANAGEMENT MARKET SEGMENTATION
  • FIGURE 2. GLOBAL HYPOTHERMIA MANAGEMENT MARKET
  • FIGURE 3. SEGMENTATION HYPOTHERMIA MANAGEMENT MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN HYPOTHERMIA MANAGEMENT MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHYPOTHERMIA MANAGEMENT MARKET
  • FIGURE 11. HYPOTHERMIA MANAGEMENT MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. HYPOTHERMIA MANAGEMENT MARKET FOR WARMING SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. HYPOTHERMIA MANAGEMENT MARKET FOR PATIENT COOLING SYSTEMS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. HYPOTHERMIA MANAGEMENT MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. HYPOTHERMIA MANAGEMENT MARKET FOR PREOPERATIVE CARE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. HYPOTHERMIA MANAGEMENT MARKET FOR ACUTE CARE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. HYPOTHERMIA MANAGEMENT MARKET FOR NEW-BORN CARE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. HYPOTHERMIA MANAGEMENT MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. HYPOTHERMIA MANAGEMENT MARKET SEGMENTATION, BY BY MEDICAL SPECIALTY
  • FIGURE 20. HYPOTHERMIA MANAGEMENT MARKET FOR CARDIOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. HYPOTHERMIA MANAGEMENT MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. HYPOTHERMIA MANAGEMENT MARKET FOR PEDIATRICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. HYPOTHERMIA MANAGEMENT MARKET FOR ORTHOPEDIC, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. HYPOTHERMIA MANAGEMENT MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: HYPOTHERMIA MANAGEMENT MARKET
  • FIGURE 31. Top player positioning, 2022
  • FIGURE 32. STRYKER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. MEDTRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. MEDTRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. ZOLL MEDICAL CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. ZOLL MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. ZOLL MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. BARD MEDICAL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. BARD MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. BARD MEDICAL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. CINCINNATI SUB-ZERO PRODUCTS, LLC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. CINCINNATI SUB-ZERO PRODUCTS, LLC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. CINCINNATI SUB-ZERO PRODUCTS, LLC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. 3M COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. 3M COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. 3M COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. SMITHS MEDICAL, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. SMITHS MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. SMITHS MEDICAL, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. GERATHERM MEDICAL AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. GERATHERM MEDICAL AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. GERATHERM MEDICAL AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. THE 37COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. THE 37COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. THE 37COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 59. INDITHERM PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. INDITHERM PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 61. INDITHERM PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 62. ATOM MEDICAL CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 63. ATOM MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 64. ATOM MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Hypothermia Management Market

Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers